Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model

Nucleolin (NCL) is highly expressed in several types of cancer and represents an interesting therapeutic target. It is expressed at the plasma membrane of tumor cells, a property which is being used as a marker for several human cancer including glioblastoma. In this study we investigated targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedetti, Elisabetta, Antonosante, Andrea, d'Angelo, Michele, Cristiano, Loredana, Galzio, Renato, Destouches, Damien, Florio, Tiziana Marilena, Dhez, Anne Chloé, Astarita, Carlo, Cinque, Benedetta, Fidoamore, Alessia, Rosati, Floriana, Cifone, Maria Grazia, Ippoliti, Rodolfo, Giordano, Antonio, Courty, José, Cimini, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747212/
https://www.ncbi.nlm.nih.gov/pubmed/26540346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747212/
https://www.ncbi.nlm.nih.gov/pubmed/26540346

Ejemplares similares